Matthew Herper highlights a STAT op-ed about a patient rejecting statins but choosing an untested peptide for cardiovascular risk, framing it as a revealing moment for evidence-based medicine.
patient rejected a statin -- one of the most tested drug classes in existence -- but chose to take an untested peptide for cardiovascular risk.
My patient is intelligent, motivated, and doing what she believes is
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare